hotspot -WSS

hotspot

author：knowledge 2025-09-28 02:29:14 - browse：725

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

hotspot

WSS

hotspot

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Baby aspirin cuts fat buildup in liver disease patients, in small study

Leading voice in opioid treatment defends methadone clinic system

UnitedHealth increases loan offers after Change Healthcare outage

Emergency medicine has repudiated 'excited delirium.' Now what?

Wikipedia

hotspot

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Future doctors should be trained to promote social change

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Heart attack and stroke risk calculators need revising

Leading voice in opioid treatment defends methadone clinic system

Medical records are filled with copy

Paying for Covid pills will soon shift to insurers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

First Opinion Podcast: How to protect health care in times of war

hotspot

Senate panel to vote on hospitals, PBMs, prisoner care

Physicians and social media: If you see something, say something?

Physicians and social media: If you see something, say something?

SCOTUS questions limit to govt efforts to fight misinformation

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Traditional Chinese medicine benefits explored in new JAMA study

Wikipedia

hotspot

focus

Wikipedia